Brief: Ono Enters Into A Drug Discovery Collaboration & Option Agreement With Shattuck Labs To Generate Bifunctional Fusion Proteins
Feb 13 (Reuters) - Ono Pharmaceutical Co Ltd 4528.T :
* ONO ENTERS INTO A DRUG DISCOVERY COLLABORATION AND OPTION
AGREEMENT WITH SHATTUCK LABS TO GENERATE BIFUNCTIONAL FUSION
PROTEINS
* ONO PHARMACEUTICAL - ONO WILL PAY TO SHATTUCK RESEARCH
FUNDING,
UP-FRONT PAYMENT, MILESTONES ON PROGRESS OF RESEARCH AND
DEVELOPMENT, COMMERCIALIZATION, UP TO $227 MILLION
Source text for Eikon: ID:
Further company coverage: 4528.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shattuck Labs
See all newsBrief: Shattuck Labs Announces Phase 2 Clinical Trial Of Sl-325 In Hidradenitis Suppurativa And Appointment Of Shoba Ravichandran, M.D., As Senior Vice President, Clinical Development
Shattuck Labs Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health